Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- 14,15-EET cPLA2i 1.0 BCD110605C16 0.28 pmol/ml of medium
- 14,15-EET cPLA2i 1.0 BCD110605C18 0.268 pmol/ml of medium
- 14,15-EET cPLA2i 1.0 BCD110605C17 0.377 pmol/ml of medium
- 14,15-EET cPLA2i 4.0 BCD110605C34 0.3 pmol/ml of medium
- 14,15-EET cPLA2i 4.0 BCD110605C36 0.315 pmol/ml of medium
- 14,15-EET cPLA2i 4.0 BCD110605C35 0.396 pmol/ml of medium
- 14,15-EET cPLA2i 20.0 BCD110605C53 0.15 pmol/ml of medium
- 14,15-EET cPLA2i 20.0 BCD110605C54 0.136 pmol/ml of medium
- 14,15-EET cPLA2i 20.0 BCD110605C52 0.213 pmol/ml of medium
- 14,15-EET PLDi 1.0 BCD110605C10 0.317 pmol/ml of medium
- 14,15-EET PLDi 1.0 BCD110605C12 0.391 pmol/ml of medium
- 14,15-EET PLDi 1.0 BCD110605C11 0.295 pmol/ml of medium
- 14,15-EET PLDi 4.0 BCD110605C30 0.317 pmol/ml of medium
- 14,15-EET PLDi 4.0 BCD110605C29 0.333 pmol/ml of medium
- 14,15-EET PLDi 4.0 BCD110605C28 0.335 pmol/ml of medium
- 14,15-EET PLDi 20.0 BCD110605C48 0.127 pmol/ml of medium
- 14,15-EET PLDi 20.0 BCD110605C47 0.138 pmol/ml of medium
- 14,15-EET PLDi 20.0 BCD110605C46 0.11 pmol/ml of medium
- 14,15-EET KDO+cPLA2i 1.0 BCD110605C19 0.487 pmol/ml of medium
- 14,15-EET KDO+cPLA2i 1.0 BCD110605C21 0.619 pmol/ml of medium
- 14,15-EET KDO+cPLA2i 1.0 BCD110605C20 0.637 pmol/ml of medium
- 14,15-EET KDO+cPLA2i 4.0 BCD110605C39 1.21 pmol/ml of medium
- 14,15-EET KDO+cPLA2i 4.0 BCD110605C37 0.818 pmol/ml of medium
- 14,15-EET KDO+cPLA2i 4.0 BCD110605C38 1.13 pmol/ml of medium
- 14,15-EET KDO+cPLA2i 20.0 BCD110605C55 0.549 pmol/ml of medium
- 14,15-EET KDO+cPLA2i 20.0 BCD110605C57 0.668 pmol/ml of medium
- 14,15-EET KDO+cPLA2i 20.0 BCD110605C56 0.795 pmol/ml of medium
- 14,15-EET KDO+PLDi 1.0 BCD110605C15 0.855 pmol/ml of medium
- 14,15-EET KDO+PLDi 1.0 BCD110605C14 0.678 pmol/ml of medium
- 14,15-EET KDO+PLDi 1.0 BCD110605C13 0.796 pmol/ml of medium
- 14,15-EET KDO+PLDi 4.0 BCD110605C32 1.3 pmol/ml of medium
- 14,15-EET KDO+PLDi 4.0 BCD110605C31 1.91 pmol/ml of medium
- 14,15-EET KDO+PLDi 4.0 BCD110605C33 1.67 pmol/ml of medium
- 14,15-EET KDO+PLDi 20.0 BCD110605C49 0.966 pmol/ml of medium
- 14,15-EET KDO+PLDi 20.0 BCD110605C51 1.07 pmol/ml of medium
- 14,15-EET KDO+PLDi 20.0 BCD110605C50 1.5 pmol/ml of medium
- 14,15-EET KDO + ATP 1.0 BCD110605C07 0.652 pmol/ml of medium
- 14,15-EET KDO + ATP 1.0 BCD110605C09 0.855 pmol/ml of medium
- 14,15-EET KDO + ATP 1.0 BCD110605C08 0.84 pmol/ml of medium
- 14,15-EET KDO + ATP 4.0 BCD110605C25 1.36 pmol/ml of medium
- 14,15-EET KDO + ATP 4.0 BCD110605C26 1.94 pmol/ml of medium
- 14,15-EET KDO + ATP 4.0 BCD110605C27 1.8 pmol/ml of medium
- 14,15-EET KDO + ATP 20.0 BCD110605C45 0.74 pmol/ml of medium
- 14,15-EET KDO + ATP 20.0 BCD110605C43 0.6 pmol/ml of medium
- 14,15-EET KDO + ATP 20.0 BCD110605C44 0.745 pmol/ml of medium
- 14,15-EET C 0.0 BCD110605C02 0.224 pmol/ml of medium
- 14,15-EET C 0.0 BCD110605C01 0.181 pmol/ml of medium
- 14,15-EET C 0.0 BCD110605C03 0.238 pmol/ml of medium
- 14,15-EET C 1.0 BCD110605C06 0.238 pmol/ml of medium
- 14,15-EET C 1.0 BCD110605C05 0.279 pmol/ml of medium